Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael Adams

Family Medicine Sandy, UT Medical Doctor

NPI 1780781682 CMS profile 216574

7998 South 1300 East, Sandy, UT 84092

Open in the dashboard

General payments

$12,089

73 records reported · program years 2019–2025

Research payments

$49,916

Paid to them · 9 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$8,102,013 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Michael Adams of Sandy, UT is reported in the CMS Open Payments database as having received $12,089 across 73 general payments and $49,916 in research payments paid to them. Separately, studies naming them as principal investigator received $8,102,013 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Family Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,887 8
2024 General $1,597 11
2024 Research $48,258 1
2023 General $4,458 27
2023 Research $535 1
2022 General $70 2
2020 Research $87 1
2019 General $4,078 25
2019 Research $1,036 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Adams
  • Family Medicine median
  • Middle half of Family Medicine
  • National median

In program year 2025, general payments to Michael Adams were reported at $1,887. Among 56,786 Family Medicine profiles paid that year, the median was $155 and the middle half received between $45 and $549.

Show as a table
Year Michael Adams Family Medicine median Middle half National median
2019 $4,078 $150 $41–$543 $163
2020 $0 $120 $32–$415 $114
2021 $0 $137 $35–$551 $132
2022 $70 $137 $37–$512 $149
2023 $4,458 $149 $42–$545 $160
2024 $1,597 $156 $44–$560 $164
2025 $1,887 $155 $45–$549 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Merck Sharp & Dohme Corporation $4,732 31 payments
  2. Allergan Inc. $1,930 9 payments
  3. Boehringer Ingelheim Pharmaceuticals, Inc. $1,887 8 payments
  4. Moderna TX, Inc. $1,530 9 payments
  5. Boehringer Ingelheim International GmbH $1,306 11 payments
  6. Novo Nordisk AS $609 2 payments
  7. Novo Nordisk Inc $97 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $9,070 31 payments
  2. Food and Beverage $2,922 39 payments
  3. Education $97 3 payments
Products named General payments · program years 2019–2025
  1. V114 $1,443 11 payments
  2. CAPVAXIVE $70 2 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Eli Lilly and Company $48,880 3 payments
  2. AbbVie, Inc. $1,036 6 payments

Records

82 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Family Medicine in Utah

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record